{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T18:11:25Z","timestamp":1773857485045,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T00:00:00Z","timestamp":1430870400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1361-3","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T11:09:26Z","timestamp":1430824166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Mechanism study of peptide GMBP1 and its receptor GRP78 in modulating gastric cancer MDR by iTRAQ-based proteomic analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Xiaojuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yani","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biaoluo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,6]]},"reference":[{"issue":"2","key":"1361_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"1361_CR2","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1007\/s00018-008-8111-5","volume":"65","author":"H Lage","year":"2008","unstructured":"Lage H. An overview of cancer multidrug resistance: a still unsolved problem. Cell Mol Life Sci. 2008;65(20):3145\u201367.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"1361_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2217\/fon.10.21","volume":"6","author":"D Zhang","year":"2010","unstructured":"Zhang D, Fan D. New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives. Future Oncol. 2010;6(4):527\u201337.","journal-title":"Future Oncol"},{"key":"1361_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","volume":"53","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med. 2002;53:615\u201327.","journal-title":"Annu Rev Med"},{"issue":"2","key":"1361_CR5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0022-3565(24)37075-2","volume":"283","author":"H Kusuhara","year":"1997","unstructured":"Kusuhara H, Suzuki H, Terasaki T, Kakee A, Lemaire M, Sugiyama Y. P-Glycoprotein mediates the efflux of quinidine across the blood\u2013brain barrier. J Pharmacol Exp Ther. 1997;283(2):574\u201380.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1361_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/carcin\/19.1.109","volume":"19","author":"CS Morrow","year":"1998","unstructured":"Morrow CS, Diah S, Smitherman PK, Schneider E, Townsend AJ. Multidrug resistance protein and glutathione S-transferase P1-1 act in synergy to confer protection from 4-nitroquinoline 1-oxide toxicity. Carcinogenesis. 1998;19(1):109\u201315.","journal-title":"Carcinogenesis"},{"issue":"3","key":"1361_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/1098-2744(200011)29:3<170::AID-MC6>3.0.CO;2-W","volume":"29","author":"CS Morrow","year":"2000","unstructured":"Morrow CS, Smitherman PK, Townsend AJ. Role of multidrug-resistance protein 2 in glutathione S-transferase P1-1-mediated resistance to 4-nitroquinoline 1-oxide toxicities in HepG2 cells. Mol Carcinog. 2000;29(3):170\u20138.","journal-title":"Mol Carcinog"},{"issue":"3","key":"1361_CR8","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/jcb.21687","volume":"104","author":"YX Yang","year":"2008","unstructured":"Yang YX, Chen ZC, Zhang GY, Yi H, Xiao ZQ. A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line. J Cell Biochem. 2008;104(3):1010\u201321.","journal-title":"J Cell Biochem"},{"issue":"3","key":"1361_CR9","first-page":"867","volume":"62","author":"F Curnis","year":"2002","unstructured":"Curnis F, Arrigoni G, Sacchi A, Fischetti L, Arap W, Pasqualini R, et al. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res. 2002;62(3):867\u201374.","journal-title":"Cancer Res"},{"issue":"9","key":"1361_CR10","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2174\/138161210790963788","volume":"16","author":"KC Brown","year":"2010","unstructured":"Brown KC. Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications. Curr Pharm Des. 2010;16(9):1040\u201354.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1361_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tibtech.2005.11.006","volume":"24","author":"MJ Vicent","year":"2006","unstructured":"Vicent MJ, Duncan R. Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechnol. 2006;24(1):39\u201347.","journal-title":"Trends Biotechnol"},{"issue":"2","key":"1361_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.canlet.2013.06.016","volume":"339","author":"J Kang","year":"2013","unstructured":"Kang J, Zhao G, Lin T, Tang S, Xu G, Hu S, et al. A peptide derived from phage display library exhibits anti-tumor activity by targeting GRP78 in gastric cancer multidrug resistance cells. Cancer Lett. 2013;339(2):247\u201359.","journal-title":"Cancer Lett"},{"issue":"3","key":"1361_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0167-7799(98)01245-1","volume":"17","author":"WP Blackstock","year":"1999","unstructured":"Blackstock WP, Weir MP. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol. 1999;17(3):121\u20137.","journal-title":"Trends Biotechnol"},{"issue":"7","key":"1361_CR14","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1101\/gr.074344.107","volume":"18","author":"N Gupta","year":"2008","unstructured":"Gupta N, Benhamida J, Bhargava V, Goodman D, Kain E, Kerman I, et al. Comparative proteogenomics: combining mass spectrometry and comparative genomics to analyze multiple genomes. Genome Res. 2008;18(7):1133\u201342.","journal-title":"Genome Res"},{"issue":"4","key":"1361_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2008.06.038","volume":"134","author":"MM Dix","year":"2008","unstructured":"Dix MM, Simon GM, Cravatt BF. Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell. 2008;134(4):679\u201391.","journal-title":"Cell"},{"issue":"5","key":"1361_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1074\/mcp.M200025-MCP200","volume":"1","author":"SE Ong","year":"2002","unstructured":"Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics. 2002;1(5):376\u201386.","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"1361_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1559-0275-8-4","volume":"8","author":"LA Rukmangadachar","year":"2011","unstructured":"Rukmangadachar LA, Kataria J, Hariprasad G, Samantaray JC, Srinivasan A. Two-dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients. Clin Proteomics. 2011;8(1):4.","journal-title":"Clin Proteomics"},{"issue":"8","key":"1361_CR18","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jprot.2009.12.004","volume":"73","author":"H Feng","year":"2010","unstructured":"Feng H, Li X, Niu D, Chen WN. Protein profile in HBx transfected cells: a comparative iTRAQ-coupled 2D LC-MS\/MS analysis. J Proteomics. 2010;73(8):1421\u201332.","journal-title":"J Proteomics"},{"issue":"8","key":"1361_CR19","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1002\/pmic.200500595","volume":"6","author":"Y Wang","year":"2006","unstructured":"Wang Y, Cheung YH, Yang Z, Chiu JF, Che CM, He QY. Proteomic approach to study the cytotoxicity of dioscin (saponin). Proteomics. 2006;6(8):2422\u201332.","journal-title":"Proteomics"},{"issue":"13","key":"1361_CR20","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1016\/j.jprot.2012.04.055","volume":"75","author":"JW Poulsen","year":"2012","unstructured":"Poulsen JW, Madsen CT, Young C, Kelstrup CD, Grell HC, Henriksen P, et al. Comprehensive profiling of proteome changes upon sequential deletion of deubiquitylating enzymes. J Proteomics. 2012;75(13):3886\u201397.","journal-title":"J Proteomics"},{"issue":"Suppl 1","key":"1361_CR21","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1002\/elps.200900051","volume":"30","author":"A Gorg","year":"2009","unstructured":"Gorg A, Drews O, Luck C, Weiland F, Weiss W. 2-DE with IPGs. Electrophoresis. 2009;30 Suppl 1:S122\u201332.","journal-title":"Electrophoresis"},{"key":"1361_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-1-60327-064-9_3","volume":"424","author":"W Weiss","year":"2008","unstructured":"Weiss W, Gorg A. Sample solublization buffers for two-dimensional electrophoresis. Methods Mol Biol. 2008;424:35\u201342.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"1361_CR23","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jprot.2009.04.003","volume":"72","author":"N Parent","year":"2009","unstructured":"Parent N, Winstall E, Beauchemin M, Paquet C, Poirier GG, Bertrand R. Proteomic analysis of enriched lysosomes at early phase of camptothecin-induced apoptosis in human U-937 cells. J Proteomics. 2009;72(6):960\u201373.","journal-title":"J Proteomics"},{"key":"1361_CR24","doi-asserted-by":"publisher","first-page":"305964","DOI":"10.1155\/2012\/305964","volume":"2012","author":"V Kolla","year":"2012","unstructured":"Kolla V, Jeno P, Moes S, Lapaire O, Hoesli I, Hahn S. Quantitative proteomic (iTRAQ) analysis of 1st trimester maternal plasma samples in pregnancies at risk for preeclampsia. J Biomed Biotechnol. 2012;2012:305964.","journal-title":"J Biomed Biotechnol"},{"issue":"3","key":"1361_CR25","doi-asserted-by":"publisher","first-page":"e1002021","DOI":"10.1371\/journal.pcbi.1002021","volume":"7","author":"P Hogeweg","year":"2011","unstructured":"Hogeweg P. The roots of bioinformatics in theoretical biology. Plos Comput Biol. 2011;7(3):e1002021.","journal-title":"Plos Comput Biol"},{"key":"1361_CR26","first-page":"571343","volume":"2010","author":"HD Hu","year":"2010","unstructured":"Hu HD, Ye F, Zhang DZ, Hu P, Ren H, Li SL. iTRAQ quantitative analysis of multidrug resistance mechanisms in human gastric cancer cells. J Biomed Biotechnol. 2010;2010:571343.","journal-title":"J Biomed Biotechnol"},{"issue":"6","key":"1361_CR27","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/pmic.200402031","volume":"6","author":"YX Yang","year":"2006","unstructured":"Yang YX, Xiao ZQ, Chen ZC, Zhang GY, Yi H, Zhang PF, et al. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901\/VCR. Proteomics. 2006;6(6):2009\u201321.","journal-title":"Proteomics"},{"issue":"7","key":"1361_CR28","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/sj.onc.1209139","volume":"25","author":"S Tsutsumi","year":"2006","unstructured":"Tsutsumi S, Namba T, Tanaka KI, Arai Y, Ishihara T, Aburaya M, et al. Celecoxib upregulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cells. Oncogene. 2006;25(7):1018\u201329.","journal-title":"Oncogene"},{"issue":"3","key":"1361_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1161\/01.HYP.32.3.459","volume":"32","author":"N Ishizaka","year":"1998","unstructured":"Ishizaka N, Griendling KK, Lassegue B, Alexander RW. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension. 1998;32(3):459\u201366.","journal-title":"Hypertension"},{"issue":"9","key":"1361_CR30","doi-asserted-by":"publisher","first-page":"e75731","DOI":"10.1371\/journal.pone.0075731","volume":"8","author":"XW Zhong","year":"2013","unstructured":"Zhong XW, Zou Y, Liu SP, Yi QY, Hu CM, Wang C, et al. Proteomic-based insight into Malpighian tubules of silkworm Bombyx mori. PLoS One. 2013;8(9):e75731.","journal-title":"PLoS One"},{"issue":"52","key":"1361_CR31","doi-asserted-by":"publisher","first-page":"48619","DOI":"10.1074\/jbc.C100613200","volume":"276","author":"W Schubert","year":"2001","unstructured":"Schubert W, Frank PG, Razani B, Park DS, Chow CW, Lisanti MP. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J Biol Chem. 2001;276(52):48619\u201322.","journal-title":"J Biol Chem"},{"issue":"14","key":"1361_CR32","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1096\/fasebj.13.14.1961","volume":"13","author":"J Gustavsson","year":"1999","unstructured":"Gustavsson J, Parpal S, Karlsson M, Ramsing C, Thorn H, Borg M, et al. Localization of the insulin receptor in caveolae of adipocyte plasma membrane. Faseb J. 1999;13(14):1961\u201371.","journal-title":"Faseb J"},{"issue":"6C","key":"1361_CR33","first-page":"4809","volume":"20","author":"K Fan","year":"2000","unstructured":"Fan K, Fan D, Cheng LF, Li C. Expression of multidrug resistance-related markers in gastric cancer. Anticancer Res. 2000;20(6C):4809\u201314.","journal-title":"Anticancer Res"},{"issue":"2","key":"1361_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/ijc.23501","volume":"123","author":"L Xia","year":"2008","unstructured":"Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer. 2008;123(2):372\u20139.","journal-title":"Int J Cancer"},{"issue":"6","key":"1361_CR35","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1074\/jbc.M112.345942","volume":"288","author":"T Li","year":"2013","unstructured":"Li T, Wang H, Sun Y, Zhao L, Gang Y, Guo X, et al. Transcription factor CUTL1 is a negative regulator of drug resistance in gastric cancer. J Biol Chem. 2013;288(6):4135\u201347.","journal-title":"J Biol Chem"},{"issue":"2","key":"1361_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/ijc.20570","volume":"113","author":"J Du","year":"2005","unstructured":"Du J, Pan Y, Shi Y, Guo C, Jin X, Sun L, et al. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901\/ADR. Int J Cancer. 2005;113(2):213\u201320.","journal-title":"Int J Cancer"},{"issue":"2","key":"1361_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0304-3835(02)00264-1","volume":"185","author":"Y Zhao","year":"2002","unstructured":"Zhao Y, You H, Liu F, An H, Shi Y, Yu Q, et al. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett. 2002;185(2):211\u20138.","journal-title":"Cancer Lett"},{"issue":"1","key":"1361_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00428-014-1588-4","volume":"465","author":"O Tapia","year":"2014","unstructured":"Tapia O, Riquelme I, Leal P, Sandoval A, Aedo S, Weber H, et al. The PI3K\/AKT\/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance. Virchows Arch. 2014;465(1):25\u201333.","journal-title":"Virchows Arch"},{"issue":"17","key":"1361_CR39","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1158\/1078-0432.CCR-03-0483","volume":"10","author":"CO Nathan","year":"2004","unstructured":"Nathan CO, Amirghahari N, Abreo F, Rong X, Caldito G, Jones ML, et al. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt\/mammalian target of rapamycin pathway. Clin Cancer Res. 2004;10(17):5820\u20137.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1361_CR40","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/onc.2012.105","volume":"32","author":"Z Nasr","year":"2013","unstructured":"Nasr Z, Robert F, Porco JJ, Muller WJ, Pelletier J. eIF4F suppression in breast cancer affects maintenance and progression. Oncogene. 2013;32(7):861\u201371.","journal-title":"Oncogene"},{"issue":"6","key":"1361_CR41","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3892\/or.2013.2397","volume":"29","author":"S Liang","year":"2013","unstructured":"Liang S, Guo R, Zhang Z, Liu D, Xu H, Xu Z, et al. Upregulation of the eIF4E signaling pathway contributes to the progression of gastric cancer, and targeting eIF4E by perifosine inhibits cell growth. Oncol Rep. 2013;29(6):2422\u201330.","journal-title":"Oncol Rep"},{"issue":"14","key":"1361_CR42","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1242\/dev.126.14.3159","volume":"126","author":"M Brannon","year":"1999","unstructured":"Brannon M, Brown JD, Bates R, Kimelman D, Moon RT. XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development. Development. 1999;126(14):3159\u201370.","journal-title":"Development"},{"issue":"50","key":"1361_CR43","doi-asserted-by":"publisher","first-page":"39762","DOI":"10.1074\/jbc.C000416200","volume":"275","author":"TA Melhuish","year":"2000","unstructured":"Melhuish TA, Wotton D. The interaction of the carboxyl terminus-binding protein with the Smad corepressor TGIF is disrupted by a holoprosencephaly mutation in TGIF. J Biol Chem. 2000;275(50):39762\u20136.","journal-title":"J Biol Chem"},{"issue":"10","key":"1361_CR44","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1242\/dev.127.10.2031","volume":"127","author":"AE Deconinck","year":"2000","unstructured":"Deconinck AE, Mead PE, Tevosian SG, Crispino JD, Katz SG, Zon LI, et al. FOG acts as a repressor of red blood cell development in Xenopus. Development. 2000;127(10):2031\u201340.","journal-title":"Development"},{"issue":"2","key":"1361_CR45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1097-2765(00)00025-3","volume":"6","author":"J Lu","year":"2000","unstructured":"Lu J, McKinsey TA, Zhang CL, Olson EN. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell. 2000;6(2):233\u201344.","journal-title":"Mol Cell"},{"issue":"22","key":"1361_CR46","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1242\/dev.125.22.4565","volume":"125","author":"Q Lin","year":"1998","unstructured":"Lin Q, Lu J, Yanagisawa H, Webb R, Lyons GE, Richardson JA, et al. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development. 1998;125(22):4565\u201374.","journal-title":"Development"},{"issue":"8","key":"1361_CR47","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1073\/pnas.0830998100","volume":"100","author":"M Grooteclaes","year":"2003","unstructured":"Grooteclaes M, Deveraux Q, Hildebrand J, Zhang Q, Goodman RH, Frisch SM. C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proc Natl Acad Sci U S A. 2003;100(8):4568\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1361_CR48","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1128\/MCB.26.6.2360-2372.2006","volume":"26","author":"S Paliwal","year":"2006","unstructured":"Paliwal S, Pande S, Kovi RC, Sharpless NE, Bardeesy N, Grossman SR. Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis. Mol Cell Biol. 2006;26(6):2360\u201372.","journal-title":"Mol Cell Biol"},{"issue":"19","key":"1361_CR49","doi-asserted-by":"publisher","first-page":"9322","DOI":"10.1158\/0008-5472.CAN-07-1743","volume":"67","author":"S Paliwal","year":"2007","unstructured":"Paliwal S, Kovi RC, Nath B, Chen YW, Lewis BC, Grossman SR. The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor. Cancer Res. 2007;67(19):9322\u20139.","journal-title":"Cancer Res"},{"issue":"1","key":"1361_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/jcb.240560108","volume":"56","author":"RS Kerbel","year":"1994","unstructured":"Kerbel RS, Kobayashi H, Graham CH. Intrinsic or acquired drug resistance and metastasis: are they linked phenotypes? J Cell Biochem. 1994;56(1):37\u201347.","journal-title":"J Cell Biochem"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1361-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1361-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1361-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1361-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T20:22:10Z","timestamp":1748377330000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1361-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,6]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1361"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1361-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,6]]},"article-number":"358"}}